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Epilepsia Partialis Continua (EPC) is a rare and notoriously treatment-refractory
form of focal motor status epilepticus, classically associated with focal involuntary
movements and cognitive impairment that can persist for weeks, months, or even 
years despite appropriate therapy with antiepileptic drugs (AEDs)1-4. It is almost 
universally caused by an underlying cortical lesion such as an infarct, neoplasm, 
congenital malformation, encephalitis, or tuberculoma1-4. Metabolic causes such as 
hyperglycemia have also been reported1,2,4.
Although the jerking movements associated with EPC are slower than most other 
forms of status epilepticus4,5, the disorder can be debilitating to affected patients, 
especially since they often require long courses of multiple AEDs to control. Given 
the rarity of this disorder (estimated less than one per million2,4), any case report
documenting effective control of EPC is noteworthy.
• Patient: 74-year-old right-handed Caucasian male.
• Presentation: altered mentation, mixed transcortical aphasia, right-sided hand and face twitching the day 
after a mechanical fall at home.
• Imaging: CT head left temporal intraparenchymal hematoma and small left frontotemporal subdural 
hematoma. CTA head/neck no underlying aneurysm or vascular malformation.
• EEG: epilepsia partialis continua, originating from left temporal leads. Routine 20-minute EEGs 
were performed daily after the initial EEG report.
• Medical history: hypertension, hyperlipidemia, depression, benign prostatic hypertrophy. Per family his 
baseline memory was declining but he could manage finances, drive alone, and converse normally.
• Medications: no antiplatelets, anticoagulants, or other home medications.
• Physical exam: repetitive, involuntary twitching of right hand, right eyelid, and right side of the mouth. 
Follows simple commands with hints and pantomiming, but often fixates on a single command. Speech 
consists of repeating a single word or syllable, although he attempts to respond to conversation.
• Treatment: started IV Levetiracetam and IV Lacosamide, titrated to maximum tolerated doses. Next 
started IV Fosphenytoin with a loading dose, and serum levels were monitored. Pulsed doses of IV methyl-
prednisolone and IV magnesium sulfate were also given. Due to a shortage of IV formulation, a PEG tube 
was placed for PO Valproate, and serum levels were monitored.
• Results: EEGs showed diminishing EPC discharges coinciding with clinical improvement, and nine days 
after presentation an EEG found only moderate bihemispheric slowing. Daily EEGs failed to show any 
recurrence of EPC.
• Modification: Titration off of four AEDs began two days after resolution of EPC. First Foshenytoin was 
weaned, then Keppra, then Lacosamide. Lamotrigine was slowly started with plans to wean Valproic acid 
after discharge.
• Follow up: CT head three weeks after presentation negative for residual blood. Contrast MRI brain 
afterwards negative for underlying lesion.
• Resolution: Involuntary movements ceased with resolution of EPC on EEG. Other clinical improvement 
followed resolution of bleeding on imaging. Three to four weeks after presentation patient appeared alert 
and was able to follow commands reliably and converse appropriately, although his memory was not at 
baseline at time of his discharge six weeks after presentation.
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The decision of which AEDs to use was based on clinical judgement in combination with 
evidence-based guidelines. A combination of medications with different mechanisms of action is 
found to be effective6,10. Primary mechanisms include that of a voltage-gated sodium channel
modulator (Lacosamide), SV2A antagonist (Levetiracetam), voltage-gated sodium channel 
antagonist (Fosphenytoin), and multiple mechanisms (Valproic acid)10. AEDs chosen have been 
shown effective both in broad spectrum and focal-specific epilepsies7. Benzodiazepines have not
been shown to be effective long-term treatment for EPC2,4. Pulsed doses of steroids and 
magnesium have also been shown to be useful in treatment-resistant status epilepticus, 
although the mechanism of action for this is uncertain8,9. Given the patient's
cognitive impairment, preference was given to AEDs available in IV formulation.
After clinical and electrophysiologic control of EPC, the decision to wean AEDs was made to 
reduce sedation and limit adverse effects. Fosphenytoin was initially weaned due to its long-
term side effect profile. Levetiracetam was then weaned due to new-onset irritable mood and 
combativeness. Lacosamide was weaned as paroxysmal atrial fibrillation was seen on EKG.
Finally, the decision was made to wean off Valproate as serum levels were labile requiring 
frequent dose adjustments. Lamotrigine was chosen for long-term therapy due to additional 
benefits of mood stabilization; however, due to the requirement for slow titration, Valproate 
was kept until Lamotrigine could be titrated to a therapeutic dose.
Epilepsia Partialis Continua typically has a poor prognosis due to difficulty controlling it with
AEDs1,5. However, with aggressive treatment and EEG monitoring this patient had a good clinical 
and electrophysiologic outcome, even with subsequent curtailing of therapy. It's possible that
EPC has a better prognosis if the underlying cause is acute rather than chronic5, however 
further study is required to elaborate on this.
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